HSBC TUR.WAR.OP.END. VX1/ DE000TT9YL52 /
27/06/2024 13:37:28 | Diferencia0.0000 | Bid14:33:08 | Ask14:33:08 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
2.1300EUR | 0.00% | 2.1300 Volumen de oferta: 50,000 |
2.1500 Tamaño/ Volumen/ Formato de Ask: 50,000 |
Vertex Pharmaceutica... | 248.5401 USD | 31/12/2078 | Call |
GlobeNewswire
14:30
ARB IOT Group Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
GlobeNewswire
14:30
Blue Star Foods Provides 2024 Revenue Guidance of At Least 65% Growth With Anticipated Annual Run-Ra...
GlobeNewswire
14:30
TSS Inc. (Total Site Solutions) Promotes Todd Marrott to Chief Operating Officer
GlobeNewswire
14:30
Comedian and Actor Drew “Druski” Desbordes Joins Safety Shot as Their Newest Brand Ambassador
GlobeNewswire
14:30
Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
GlobeNewswire
14:30
Nasdaq Private Market Elects Industry Veteran Louis Citron As New Independent Board Member
GlobeNewswire
14:30
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to ProgenaCare Global
GlobeNewswire
14:30
CytoDyn Announces Start of Preclinical MASH Study, Results Expected in Fall 2024
GlobeNewswire
14:30
Femasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting ...
GlobeNewswire
14:27
Aeroflow Health Launches Personalized Nutrition Services, Harnessing the Power of Food to Improve He...
GlobeNewswire
14:26
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...
GlobeNewswire
14:18
Medicenna Therapeutics Reports Fiscal Year 2024 Financial Results and Operational Highlights
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página